The medical advice for people at this point is tentative
Rapid weight loss, which is common with high-efficacy GLP-1 agonists, can exacerbate this ratio
Li Y, Cui J, Liu L, Hambright WS, Gan Y, Zhang Y, et al
Zepbound, the formulation of tirzepatide approved for weight loss, has shown significant success in clinical trials
GLP-1 medications suppress appetite significantly, which means many women are eating considerably less in the first weeks of treatment than their body is used to
With a score of 7.8 out of 10, the company focuses on delivering quick consultations, tailored treatment plans, and direct access to licensed medical professionals